Literature DB >> 23966392

Latency locus complements MicroRNA 155 deficiency in vivo.

Sang-Hoon Sin1, Yong Baek Kim, Dirk P Dittmer.   

Abstract

MicroRNA-155 (miR-155) is expressed in many cancers. It also executes evolutionary conserved functions in normal B cell development. We show that the Kaposi's sarcoma-associated herpesvirus (KSHV) latency locus, which contains an ortholog of miR-155, miR-K12-11, complements B cell deficiencies in miR-155 knockout mice. Germinal center (GC) formation was rescued in spleen, lymph node, and Peyer's patches. Immunoglobulin levels were restored. This demonstrates that KSHV can complement the normal, physiological function of miR-155.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23966392      PMCID: PMC3807310          DOI: 10.1128/JVI.01620-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.

Authors:  Anke van den Berg; Bart-Jan Kroesen; Klaas Kooistra; Debora de Jong; Jane Briggs; Tjasso Blokzijl; Susan Jacobs; Joost Kluiver; Arjan Diepstra; Ewerton Maggio; Sibrand Poppema
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

2.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

3.  A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.

Authors:  D Dittmer; M Lagunoff; R Renne; K Staskus; A Haase; D Ganem
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

Authors:  Peggy S Eis; Wayne Tam; Liping Sun; Amy Chadburn; Zongdong Li; Mario F Gomez; Elsebet Lund; James E Dahlberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

5.  Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR.

Authors:  Farnaz D Fakhari; Dirk P Dittmer
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation.

Authors:  S Sato; D A Steeber; T F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.

Authors:  Joseph H Jeong; Rebecca Hines-Boykin; John D Ash; Dirk P Dittmer
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma.

Authors:  Farnaz D Fakhari; Joseph H Jeong; Yogita Kanan; Dirk P Dittmer
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

9.  Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

10.  Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice.

Authors:  D Dittmer; C Stoddart; R Renne; V Linquist-Stepps; M E Moreno; C Bare; J M McCune; D Ganem
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  16 in total

Review 1.  Animal models of tumorigenic herpesviruses--an update.

Authors:  Dirk P Dittmer; Blossom Damania; Sang-Hoon Sin
Journal:  Curr Opin Virol       Date:  2015-10       Impact factor: 7.090

2.  Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.

Authors:  Sang-Hoon Sin; Anthony B Eason; Rachele Bigi; Yongbaek Kim; SunAh Kang; Kelly Tan; Tischan A Seltzer; Raman Venkataramanan; Hyowon An; Dirk P Dittmer
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 3.  Physiological roles of miR-155.

Authors:  Ryuichi Mashima
Journal:  Immunology       Date:  2015-05-19       Impact factor: 7.397

Review 4.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 5.  In Vivo Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Ariana G Bravo Cruz; Blossom Damania
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

6.  Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation.

Authors:  Sang-Hoon Sin; Sun Ah Kang; Yongbaek Kim; Anthony Eason; Kelly Tan; Hyowon An; Dirk P Dittmer
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms.

Authors:  Sara Botto; Jennifer E Totonchy; Jean K Gustin; Ashlee V Moses
Journal:  MBio       Date:  2015-06-04       Impact factor: 7.867

8.  Analysis of the mRNA targetome of microRNAs expressed by Marek's disease virus.

Authors:  Oren Parnas; David L Corcoran; Bryan R Cullen
Journal:  MBio       Date:  2014-01-21       Impact factor: 7.867

Review 9.  Involvement of eukaryotic small RNA pathways in host defense and viral pathogenesis.

Authors:  Julie Hicks; Hsiao-Ching Liu
Journal:  Viruses       Date:  2013-10-30       Impact factor: 5.048

Review 10.  Emerging Roles of Herpesvirus microRNAs During In Vivo Infection and Pathogenesis.

Authors:  Emily R Feldman; Scott A Tibbetts
Journal:  Curr Pathobiol Rep       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.